Gyre Therapeutics, Inc. (GYRE)

NASDAQ: GYRE · IEX Real-Time Price · USD
17.48
-0.05 (-0.29%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Total Valuation

GYRE has a market cap or net worth of $19.42 million. The enterprise value is -$13.68 million.

Market Cap 19.42M
Enterprise Value -13.68M

Important Dates

The last earnings date was Tuesday, March 26, 2024, before market open.

Earnings Date Mar 26, 2024
Ex-Dividend Date n/a

Share Statistics

GYRE has 85.37 million shares outstanding. The number of shares has decreased by -13.02% in one year.

Shares Outstanding 85.37M
Shares Change (YoY) -13.02%
Shares Change (QoQ) +2,500.21%
Owned by Insiders (%) 27.73%
Owned by Institutions (%) 8.75%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.17
Forward PS n/a
PB Ratio n/a
P/FCF Ratio 1.08
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.85

Current Ratio 2.85
Quick Ratio 2.75
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF 0.02
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -235.80%
Return on Capital (ROIC) n/a
Revenue Per Employee $16.21M
Profits Per Employee -$13.28M
Employee Count 7
Asset Turnover 2.88
Inventory Turnover 0.89

Taxes

In the past 12 months, GYRE has paid $8.52 million in taxes.

Income Tax 8.52M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +513.33% in the last 52 weeks. The beta is 1.29, so GYRE's price volatility has been higher than the market average.

Beta (1Y) 1.29
52-Week Price Change +513.33%
50-Day Moving Average 16.77
200-Day Moving Average 12.37
Relative Strength Index (RSI) 48.75
Average Volume (30 Days) 85,055

Short Selling Information

The latest short interest is 34,049, so 0.04% of the outstanding shares have been sold short.

Short Interest 34,049
Short Previous Month 71,894
Short % of Shares Out 0.04%
Short % of Float n/a
Short Ratio (days to cover) 0.19

Income Statement

In the last 12 months, GYRE had revenue of $113.45 million and -$92.93 million in losses. Loss per share was -$1.41.

Revenue 113.45M
Gross Profit 108.81M
Operating Income -67.23M
Pretax Income -84.42M
Net Income -92.93M
EBITDA -82.99M
EBIT -84.42M
Loss Per Share -$1.41
Full Income Statement

Balance Sheet

The company has $33.51 million in cash and $409,000 in debt, giving a net cash position of $33.10 million or $0.39 per share.

Cash & Cash Equivalents 33.51M
Total Debt 409,000
Net Cash 33.10M
Net Cash Per Share $0.39
Equity / Book Value -15.83M
Book Value Per Share -0.19
Working Capital 37.17M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $25.89 million and capital expenditures -$7.85 million, giving a free cash flow of $18.04 million.

Operating Cash Flow 25.89M
Capital Expenditures -7.85M
Free Cash Flow 18.04M
FCF Per Share $0.27
Full Cash Flow Statement

Margins

Gross margin is 95.91%, with operating and profit margins of -59.26% and -81.92%.

Gross Margin 95.91%
Operating Margin -59.26%
Pretax Margin -74.41%
Profit Margin -81.92%
EBITDA Margin -73.15%
EBIT Margin -74.41%
FCF Margin 15.90%

Dividends & Yields

GYRE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 13.02%
Shareholder Yield 13.02%
Earnings Yield -478.59%
FCF Yield 92.90%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on February 13, 2017. It was a reverse split with a ratio of 1:15.

Last Split Date Feb 13, 2017
Split Type Reverse
Split Ratio 1:15

Scores

GYRE has an Altman Z-Score of -1.76 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.76
Piotroski F-Score 4